A new type of nanoparticle developed in the laboratories at the University of North Carolina has shown potential for more effective delivery of chemotherapy to treat cancer. Wenbin Lin, PhD, Kenan Distinguished Professor ...
Bio & Medicine
Sep 20, 2011
0
0
A team of researchers from four Boston-area institutions led by Nicusor Iftimia from Physical Sciences, Inc. has demonstrated for the first time that optical coherence tomography (OCT), a high resolution optical imaging technique ...
Optics & Photonics
Aug 17, 2011
0
0
Two new papers in the Journal of General Physiology demonstrate the successes of using bifurcation theory and dynamical systems approaches to solve biological puzzles.
Cell & Microbiology
Jun 27, 2011
0
0
A new low cost test for acute pancreatitis that gets results much faster than existing tests has been developed by scientists at The University of Texas at Austin.
Analytical Chemistry
Apr 25, 2011
0
101
(PhysOrg.com) -- Researchers at The University of Texas at Arlington are perfecting a system to detect a gene mutation implicated in 90 percent of pancreatic cancers and often in lung cancer by running tiny amounts of blood ...
Bio & Medicine
Mar 11, 2011
0
0
A five-year, $16-million grant from the National Cancer Institute will take advantage of specialized expertise developed by scientists at Albert Einstein College of Medicine of Yeshiva University and Montefiore, the University ...
Bio & Medicine
Jan 3, 2011
0
0
Men with type 1 diabetes may be able to grow their own insulin-producing cells from their testicular tissue, say Georgetown University Medical Center (GUMC) researchers who presented their findings today at the American Society ...
Cell & Microbiology
Dec 12, 2010
6
0
One of the most frustrating problems faced by doctors who treat pancreatic cancer is the lack of effective therapeutic options. More than 38,000 people in the United States die of the disease each year, and new drugs and ...
Biochemistry
Nov 5, 2010
0
0
By combining an iron oxide nanoparticle, a tumor-targeting peptide, and a therapeutic nucleic acid into one construct, a team of investigators from the Massachusetts General Hospital and Harvard Medical School have created ...
Bio & Medicine
Oct 28, 2010
0
0
Scientists have found that a synthetic molecule they designed can block activation of a gene in liver cancer cells, halting a process that allows some of those cancer cells to survive chemotherapy.
Biochemistry
Oct 12, 2010
0
0
